Antibe Therapeutics Inc(Pre-Merger) ATBPF

Viral infection

[Ryeman40]

I wonder if this is what they are looking at for covid-19
researchers from Ohio State University found that out of more than two dozen athletes from the university who tested positive for COVID-19, 30% had cellular heart damage and 15% showed signs of heart inflammation caused by a condition known as myocarditis.
"Cardiac magnetic resonance imaging has the potential to identify a high-risk cohort for adverse outcomes and may, importantly, risk-stratify athletes for safe participation," study authors wrote. "Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), even in asymptomatic or mildly symptomatic patients."
From their patent with Antibe Holdings
The compounds would also be useful in the treatment of pulmonary inflammation, such as that associated with viral infections and cystic fibrosis.
Myocarditis is usually caused by a viral infection. 
Food for thought anyway.